Related Experiment Video
Updated: Jul 13, 2026
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Exploring experiential learning opportunities in pharmacogenomics for pharmacy education
Nicole Keuler1, Jane McCartney1, Renier Coetzee2
1School of Pharmacy, University of the Western Cape, Cape Town, South Africa.
Pharmacogenomics
|December 23, 2025
Summary
Pharmacogenomics (PGx) clinics provide valuable hands-on learning for pharmacy students. These experiences prepare future pharmacists for precision medicine by developing essential clinical and research skills.
Area of Science:
- Pharmacogenomics (PGx)
- Precision Medicine
- Pharmacy Education
Background:
- Pharmacists are crucial in advancing precision medicine through pharmacogenomics (PGx).
- Experiential learning in clinical PGx settings is vital for developing practical skills.
Purpose of the Study:
- To explore and identify experiential learning opportunities within pharmacogenomics (PGx) clinics for pharmacy education.
Main Methods:
- Qualitative study involving observations of four US-based PGx clinics.
- Semi-structured interviews with four pharmacists practicing in PGx clinics.
Main Results:
- Identified diverse learning opportunities: knowledge/skill development, research, interprofessional collaboration, patient education, comprehensive care, evidence-based practice, and leadership.
- PGx clinics offer multifaceted experiential learning relevant to clinical practice.
Conclusions:
- Pharmacogenomics clinics are rich environments for pharmacy experiential learning.
- Collaboration between healthcare and academic institutions is key to establishing these PGx learning opportunities.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...